Symptom Clusters in Children With Exacerbation-prone Asthma

Completed · Phase 2

Conditions studied: Asthma in Children

In brief

Pediatric participants with exacerbation-prone asthma will receive an intramuscular injection of triamcinolone acetonide and will be followed for 48 weeks. The study visit 2 weeks after the injection will assess the response to the study medication, while the remaining study visits will examine the temporal stability of the symptom clusters.

Key facts

Study ID
NCT04002362
Run by
Emory University
People needed
68
Starts
2019-11-13
Expected to finish
2025-12-24
Last updated by the study team
2026-02-13

Who can join

Age: 6 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.